News
Important Only
GLOBAL MARKETS-US stocks edge up, yields fall as US CPI data cooler than expected
Dow, S&P 500 end barely higher; Nasdaq downDollar was last flat while yields were downUS January inflation data softer than expectedAluminum prices fall after report on tariffs By Caroline Valetkevitch NEW YORK, Feb 13 (Reuters) - Wall Street indexes ended mostly with a slight gain while Tre...Reuters
an hour ago
US STOCKS-S&P 500 ends up slightly as tech dips, inflation cools
Indexes: Dow up 0.10%, S&P 500 up 0.05%; Nasdaq off 0.22%US inflation increases less than expected in JanuaryApplied Materials jumps after upbeat Q2 earnings forecastDefensive utilities, real estate sectors outperformBy Sinéad Carew and Twesha Dikshit Feb 13 (Reuters) - The S&P 500 c...Reuters
an hour ago
Top 5 US Stock Gainers/Losers (>100B) (2.13)
Applied Materials(AMAT) rose 8.08%, with a trading turnover 5.7 Billion USD, and a year-to-date rose 38.1%. Newmont(NEM) rose 6.5%, with a trading turnover 947.7 Million USD, and a year-to-date rose 26%. Visa(V) fell 3.12%, with a trading turnover 3.7 Billion USD, and a year-to-date fell 10.3%. Banco Bilbao Vizcaya Argentaria(BBVA) fell 2.57%, with a trading turnover 200.4 Million USD, and a year-to-date fell 2.5%.Longport
2 hours ago
Top 5 CDRs Gainers/Losers (>100M) (2.13)
Troops(TROO) rose 8.12%, with a trading turnover 4.9 Million USD, and a year-to-date rose 29.1%. Silvercorp Met(SVM) rose 7.86%, with a trading turnover 36.9 Million USD, and a year-to-date rose 31.7%. ECARX(ECX) fell 6.78%, with a trading turnover 5.7 Million USD, and a year-to-date fell 4.1%. So-Young(SY) fell 5.8%, with a trading turnover 2.9 Million USD, and a year-to-date rose 27%.Longport
2 hours ago
Top 10 US Stock Gainers (2.13)
Corsair Gaming(CRSR) rose 48.25%, with a trading turnover 332.3 Million USD, and a year-to-date rose 14.3%. Cooper-Standard(CPS) rose 32.36%, with a trading turnover 50.9 Million USD, and a year-to-date rose 37.7%. Tri Pointe Homes(TPH) rose 26.8%, with a trading turnover 1.0 Billion USD, and a year-to-date rose 47.3%.Longport
2 hours ago
Top 10 US Stock Losers (2.13)
Disc Medicine(IRON) fell 21.91%, with a trading turnover 256.3 Million USD, and a year-to-date fell 29.5%. Bright Horizons Family Solutions(BFAM) fell 18.25%, with a trading turnover 273.4 Million USD, and a year-to-date fell 34%. Fortune Brands Innovations(FBIN) fell 17.62%, with a trading turnover 950.6 Million USD, and a year-to-date rose 2.6%.Longport
2 hours ago
US stocks weekly: AI aftershocks
S&P 500 .SPX drops 1.4% as artificial intelligence worries reverberate .NDow .DJI loses 1.2%, Nasdaq Composite .IXIC tumbles 2.1%S&P 500 comes within striking distance of highs, 7,000 milestone, then retreats again, though tests 100-DMA support on Fri, bouncesAnd in the wake of the tech wrec...Reuters
2 hours ago
DIARY-Federal Reserve Events
Denotes a new entry. -------------------------------------------------------- Federal Open Market Committee (FOMC) MEETING DATES: 2026March 17-18 (second day: statement released 1400 EDT/1800 GMT; news conference expected 1430 EDT/1830 GMT)April 28-29 (second day: statement released...Reuters
2 hours ago
CORRECTED-US STOCKS-S&P 500 ends up slightly as tech dips, inflation cools
US inflation increases less than expected in JanuaryApplied Materials jumps after upbeat Q2 earnings forecastDefensive sectors outperformBy Sinéad Carew and Twesha Dikshit Feb 13 (Reuters) - The S&P 500 closed barely higher on Friday, with technology and communications services down on na...Reuters
2 hours ago
CANADA STOCKS-TSX rallies as US inflation data boosts commodity prices
TSX ends up 1.9% at 33,073.71For the week, the index adds 1.9%Materials group jumps 4.4% as gold ralliesMagna soars 18.9% on profit forecastBy Fergal Smith Feb 13 (Reuters) - Canada's main stock index rebounded on Friday, led by gains for Magna and commodity-linked shares, as softer-than-expe...Reuters
2 hours ago
Elevance Health Inc Stock Closed Up by 3.12% on Feb 13: What Investors Need To Know
• Institutional investors increased Elevance Health stake significantly. • Elevance Health raised its quarterly dividend to $1.72 per share. • Q4 2025 earnings per share surpassed analyst estimates.
TradingKey
3 hours ago
LIVE MARKETS-Rate cut hopes battle tech concerns
Nasdaq dips; Dow, S&P 500 post minor gainsUtilities leads S&P 500 sector gainers; Comm Svcs weakest groupDollar dip; crude edges up; gold up >2%; bitcoin up >4.5%US 10-Year Treasury yield falls to ~4.05%Welcome to the home for real-time coverage of markets brought to you by Reuters rep...Reuters
3 hours ago
US FDA declines to approve Disc Medicine's rare disease drug
Feb 13 (Reuters) - Disc Medicine IRON.O said on Friday the U.S. Food and Drug Administration has declined to approve its drug to treat a rare genetic disorder, sending its shares down more than 20% by the close.The company was seeking approval for its experimental drug bitopertin as a treatment for ...Reuters
3 hours ago
EMERGING MARKETS-Latam stocks, FX on track to cap data-heavy week with gains
Latam stocks fall 1.3% Forex eases 0.7%Peru gathers support for debate to oust President JeriBy Pranav Kashyap and Ragini Mathur Feb 13 (Reuters) - Latin American currencies were mixed on Friday as regional stocks sent conflicting signals and investors digested a week packed with high-impact econ...Reuters
3 hours ago
GLOBAL MARKETS-Stocks inch lower; yields fall as US CPI data cooler than expected
Wall Street stocks slightly higherDollar was last flat while yields were downUS January inflation data softer than expectedAluminum prices fall after report on tariffs By Caroline Valetkevitch NEW YORK, Feb 13 (Reuters) - Wall Street indexes were slightly lower in choppy trading while Treasury y...Reuters
3 hours ago
Disc Medicine dives as FDA declines to approve rare disease drug
Disc Medicine's IRON.O shares down 28.4% at $51.3Blood disease-focused biopharma says U.S. FDA has declined to approve Bitopertin, its rare genetic disorder treatmentBitopertin has been under review for accelerated approval and as part of the Commissioner's National Priority Voucher pilot pr...Reuters
3 hours ago
Vertex Pharmaceuticals Inc Stock Moved Up by 6.51% on Feb 13: What Signal Does It Send?
• Vertex Pharmaceuticals beat revenue estimates, exceeding analyst expectations. • Analysts issued positive ratings, with Oppenheimer upgrading to "Outperform." • Vertex projects 8-9% revenue growth for 2026, with over $500 million from non-CF products.
TradingKey
4 hours ago
US STOCKS-Wall St indexes rises as tech steadies, inflation cools
Indexes up: Dow 0.33%, S&P 500 0.48%, Nasdaq 0.35%US inflation increases less than expected in JanuaryS&P 500, Dow headed for biggest weekly decline since NovemberApplied Materials jumps after upbeat Q2 earnings forecastBy Sinéad Carew and Twesha Dikshit Feb 13 (Reuters) - U.S. stocks...Reuters
4 hours ago
CORRECTED-Incyte's weak Opzelura 2026 revenue forecast heightens Jakafi patent concerns (Feb 10)
Feb 10 (Reuters) - Incyte INCY.O forecast Opzelura annual sales below Wall Street estimates on Tuesday, raising concerns about the drugmaker which faces looming patent losses on top-seller Jakafi.Shares of the Wilmington, Delaware-based company fell over 4% in premarket trading.Incyte expects 2026 n...Reuters
4 hours ago
